SHARE
COPY LINK

COVID-19

Coronavirus: EU warns healthcare capacity could be exceeded

The risk is high that European healthcare systems will be overwhelmed by the new coronavirus outbreak, the EU's health agency warns.

Coronavirus: EU warns healthcare capacity could be exceeded
The European Centre for Disease Prevention and Control in Stockholm. Photo: Jonathan Nackstrand/AFP

The European Centre for Disease Prevention and Control (ECDC) also called for a slew of measures to be implemented to halt the spread of the deadly disease – including quarantines of confirmed or suspected carriers and bans on mass gatherings.

The Stockholm-based agency said on Thursday that systems in EU countries and the European Economic Area (EAA) – Iceland, Lichtenstein and Norway – along with Britain could be overstretched.

“The risk of healthcare system capacity being exceeded in the EU/EAA and the UK in the coming weeks is considered high,” the ECDC said in a statement.

It also recommended “social distancing” measures at workplaces and cancellation of non-essential work travel and meetings, as well as measures to be taken at schools, including possible closures.

And it urged “cordon… of residential areas with high levels of community transmission”.

Meanwhile, the EU Commissioner for Health and Food Safety, Stella Kyriakides, said in a Twitter post that measures to curb the spread of the disease were “more than ever necessary across EU”.

“Only with aggressive containment action can we delay the transmission of COVID-19. Many member states have already taken far-reaching measures, impacting the daily lives of our citizens and economy,” Kyriakides said.

There are more than 22,000 people infected in Europe, where nearly 950 people have died from the illness. The vast majority, however, experience only mild symptoms and fully recover.

Member comments

Log in here to leave a comment.
Become a Member to leave a comment.

COVID-19

Covid-19 medicine Paxlovid now available in Denmark

Denmark has received its first supply of Paxlovid, an antiviral treatment for Covid-19.

Covid-19 medicine Paxlovid now available in Denmark

A first stock of Paxlovid, a tablet which can be described by doctors to combat Covid-19 symptoms, has been delivered to Denmark, health authorities confirmed in a statement.

“The first delivery has arrived today and the rest will be delivered continuously during the coming period,” the Danish Health Authority said.

Denmark has purchased 40,000 treatment courses of the medicine.

Doctors decide when to prescribe the medicine, which is suitable for adults infected with Covid-19 who are at risk of serious illness with Covid-19. It is taken over a course of five days when symptoms are still mild.

“Treatment with Paxlovid is for the patients who are at greatest risk of serious illness with Covid-19 and the treatment will be an important part of the future management of Covid-19,” the Health Authority said in the statement.

The arrival of a medicine for Covid-19 does not signal the end of vaccination which remains “the most effective measure to prevent serious illness and death,” it said.

Denmark has purchased the Paxlovid supply through a deal with pharmaceutical company Pfizer.

The infectious disease control agency State Serum Institute (SSI) has 2.2 million Covid-19 vaccines which have been in storage for so long that they are no longer usable, news wire Ritzau earlier reported.

The vaccines were purchased when Denmark was acquiring as many as possible during the pandemic but because they are not effective against newer variants of the coronavirus, they can no longer be used.

Another 3.6 million doses in storage at SSI can only be used for the initial two doses for as-yet unvaccinated people – who are now limited in number given Denmark’s high vaccine uptake. This means they are unusable in the current booster programme.

The cost of the 5.8 million vaccines is estimated at between 116 and 783 million kroner.

SHOW COMMENTS